1. Home
  2. PXED vs NEO Comparison

PXED vs NEO Comparison

Compare PXED & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PXED

Phoenix Education Partners Inc.

N/A

Current Price

$33.11

Market Cap

1.0B

Sector

Real Estate

ML Signal

N/A

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$14.17

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PXED
NEO
Founded
1976
2001
Country
United States
United States
Employees
3400
N/A
Industry
Other Consumer Services
Precision Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
PXED
NEO
Price
$33.11
$14.17
Analyst Decision
Buy
Strong Buy
Analyst Count
7
8
Target Price
$44.29
$13.38
AVG Volume (30 Days)
82.1K
2.9M
Earning Date
04-07-2026
04-28-2026
Dividend Yield
3.07%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.85
$10.63
Revenue Next Year
$4.49
$9.73
P/E Ratio
$11.20
N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.52
$4.72
52 Week High
$38.19
$13.88

Technical Indicators

Market Signals
Indicator
PXED
NEO
Relative Strength Index (RSI) 59.69 78.61
Support Level $28.40 $11.49
Resistance Level $33.05 N/A
Average True Range (ATR) 1.34 0.65
MACD 0.07 0.24
Stochastic Oscillator 91.44 94.98

Price Performance

Historical Comparison
PXED
NEO

About PXED Phoenix Education Partners Inc.

Phoenix Education Partners Inc. is a mission-driven organization operating at the forefront of the rapidly evolving post-secondary education market. it is an online education provider and a pioneer in its field. The company benefits from the dynamic interplay between technological innovation, education, employment, and economic trends. It is focused on delivering personalized, career-relevant, and affordable education to its students through its flexible learning model, skills-aligned curriculum, and accessible tuition costs.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: